Dow Up 1.34% Nasdaq Up 0.89%

NewLink Genetics Corporation (NLNK)

-NasdaqGM
20.37 Down 0.17(0.83%) 1:23PM EST - Nasdaq Real Time Price
Prev Close:20.54
Open:20.67
Bid:20.32 x 400
Ask:20.45 x 500
1y Target Est:58.20
Beta:1.73705
Earnings Date:Feb 24 - Feb 29 (Est.)
Day's Range:19.80 - 21.46
52wk Range:19.75 - 58.73
Volume:225,401
Avg Vol (3m):457,576
Market Cap:586.35M
P/E (ttm):5.94
EPS (ttm):3.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NLNK

Comparison

Symbol% ChgMkt Cap
NLNKDown 0.83%586.35M
LLYDown 0.12%75.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.55
Quarterly EPS Est (Dec-15) :-0.92
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback